This may help: From the Investor Presentation. Advangen revenue ($m, June YE) FY2017 revenue by region USA was at 3% for last years FY Be interesting to see what it is for this one.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come